TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head. September 9, 2005
TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 12, 1974
TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
